NN is trading at $3.39, down 10.75% in pre-market on October 29, with no specific negative catalyst identified.

  • Q3 sales were $131.1 million, up 26.2% year over year; NN raised its 2026 outlook.
  • Shares are below the October 28 close of $3.80. The Nasdaq Composite was down 1.09% in the supplied pre-market context, but there is no evidence this explains NN’s larger decline.
  • The earnings call is scheduled for 9 a.m. ET.